Photodynamic therapy for cancer of the pancreas – The story so far
- 6 April 2016
- journal article
- research article
- Published by Walter de Gruyter GmbH in Photonics & Lasers in Medicine
- Vol. 5 (2), 91-100
- https://doi.org/10.1515/plm-2016-0001
Abstract
Background and objective: Pancreatic cancer has long been a leading cause of cancer death. Few patients are suitable for surgery and for those who are not, the response to treatment is generally poor. No more than about 10% survive for more than a year. Recent research has focused on focal treatment for local disease control. This review covers the development of one of the most promising options, photodynamic therapy (PDT). Methods: This review covers pre-clinical and clinical studies. Laboratory work was designed to understand the effect of PDT on the normal pancreas and surrounding tissues and on transplanted cancers in the hamster pancreas to ensure safety prior to clinical application. Essentially all clinical studies have been undertaken in University College Hospital, London. Phase-I studies used the photosensitisers mTHPC and verteporfin in patients with localised but inoperable cancers. Results: Laboratory results showed that normal pancreas, bile duct, liver, stomach and major blood vessels could tolerate PDT without any unacceptable effects on the structure and function of these organs. Necrosis that healed safely was documented in transplanted cancers. The clinical trials showed that focal necrosis could be produced in inoperable cancers with acceptable levels of complications, but considerable refinements of treatment delivery and monitoring are required before the technique will be ready for assessment in controlled clinical trials. Conclusions: PDT is showing promise for the minimally invasive treatment of localised pancreatic cancers, but it is still at an early stage of development. Much more work will be necessary to optimise techniques for applying PDT to these cancers and for combining it with other therapeutic options such as chemotherapy.Keywords
This publication has 29 references indexed in Scilit:
- The Incidence and Survival Rate of Population-Based Pancreatic Cancer Patients: Shanghai Cancer Registry 2004–2009PLOS ONE, 2013
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerThe New England Journal of Medicine, 2011
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic CancerJournal of Clinical Oncology, 2009
- EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video)Gastrointestinal Endoscopy, 2008
- Long-term safety and efficacy of superficial femoral artery angioplasty with adjuvant photodynamic therapy to prevent restenosisBritish Journal of Surgery, 2002
- Photodynamic therapy for cancer of the pancreasGut, 2002
- The effect of photodynamic therapy on the mechanical integrity of normal rabbit carotid arteriesThe Laryngoscope, 1995
- Experimental pancreatic cancer in the rat treated by photodynamic therapyBritish Journal of Surgery, 1994
- Selective necrosis in hamster pancreatic tumours using photodynamic therapy with phthalocyanine photosensitizationBritish Journal of Surgery, 1992
- Interstitial laser hyperthermia: a new approach to local destruction of tumours.BMJ, 1989